Literature DB >> 21788765

Impact of Crohn disease on eosinophilic esophagitis: evidence for an altered T(H)1-T(H)2 immune response.

Daniel J Mulder1, Lawrence C Hookey, David J Hurlbut, Christopher J Justinich.   

Abstract

Entities:  

Mesh:

Year:  2011        PMID: 21788765     DOI: 10.1097/MPG.0b013e318213bf79

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


× No keyword cloud information.
  7 in total

Review 1.  Eosinophilic Esophagitis.

Authors:  Glenn T Furuta; David A Katzka
Journal:  N Engl J Med       Date:  2015-10-22       Impact factor: 91.245

2.  Screening children for eosinophilic esophagitis: allergic and other risk factors.

Authors:  Melanie A Ruffner; Peter Capucilli; David A Hill; Jonathan M Spergel
Journal:  Expert Rev Clin Immunol       Date:  2019-02-20       Impact factor: 4.473

3.  Increased Prevalence of Esophageal Eosinophilia in Patients with Inflammatory Bowel Disease.

Authors:  Y Claire Fan; David Steele; Bharati Kochar; Diana Arsene; Millie D Long; Evan S Dellon
Journal:  Inflamm Intest Dis       Date:  2019-03-20

4.  First Therapeutic Approval for Eosinophilic Esophagitis.

Authors:  Rami A Al-Horani; Raquel Chiles
Journal:  Gastroenterol Insights       Date:  2022-07-30

5.  Risk of fractures in individuals with eosinophilic esophagitis: nationwide population-based cohort study.

Authors:  John J Garber; Bjorn Roelstraete; Paul J Lochhead; Amiko M Uchida; Karl Michaëlsson; Ola Olén; Jonas F Ludvigsson
Journal:  Esophagus       Date:  2022-06-28       Impact factor: 3.671

6.  Patients with inflammatory bowel disease have increased risk of autoimmune and inflammatory diseases.

Authors:  Morten L Halling; Jens Kjeldsen; Torben Knudsen; Jan Nielsen; Lars Koch Hansen
Journal:  World J Gastroenterol       Date:  2017-09-07       Impact factor: 5.742

7.  Prevalence of Autoimmune Disease in Patients with Eosinophilic Esophagitis: A Cross-sectional Study of Three Hospitals in Japan.

Authors:  Maki Ayaki; Noriaki Manabe; Minoru Fujita; Ryo Katsumata; Jun Nakamura; Tomoari Kamada; Masayuki Murota; Kazuhiko Inoue; Ken Haruma
Journal:  Intern Med       Date:  2021-05-22       Impact factor: 1.271

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.